Latest S-1 registration statements

Contineum Therapeutics, a clinical-stage biopharmaceutical company, is seeking to raise approximately $150 million through an initial public offering to advance its pipeline of therapies for neuroscience, inflammation, and immunology indications.

Calidi Biotherapeutics plans to offer common stock units and pre-funded warrant units to raise capital.

Richtech Robotics has filed an amendment to its S-1 registration statement, outlining the potential resale of up to 12,983,208 shares of Class B common stock by YA II PN, Ltd. following a standby equity purchase agreement.

Panbela Therapeutics is registering the resale of up to 255,600 shares of its common stock by selling securityholders, while facing challenges with Nasdaq listing compliance.

CleanCore Solutions, Inc. files Amendment No. 7 to its Form S-1 registration statement, primarily to include updated exhibits.

Aptevo Therapeutics is launching a public offering of common stock and warrants to raise capital for clinical programs and general corporate purposes.

Acurx Pharmaceuticals is offering 12,019,230 shares of common stock to raise approximately $22.9 million for working capital and clinical trials.

Lenz Therapeutics registers for the resale of 1,297,411 shares of common stock issued in a PIPE financing following its merger with Graphite Bio.

Tivic Health Systems is seeking to raise capital through a best efforts offering of common stock and warrants to fund working capital and general corporate purposes.

Nascent Biotech aims to raise capital for Phase 2 clinical trials and administrative expenses through a stock offering involving the sale and resale of common stock and warrants.

PHI Group, a leading provider of flight services for the oil and gas and air medical industries, has filed an S-1/A form for an initial public offering, seeking to fund growth and general corporate purposes.

Cheetah Net Supply Chain Service Inc. aims to raise capital through a public offering of Class A common stock to fund working capital and expand warehousing and logistics services.

Know Labs has filed a registration statement for the potential resale of up to 10.8 million shares of its common stock by a selling stockholder.

Bitwise is seeking SEC approval for its Ethereum ETF, aiming to provide investors with exposure to ether through a regulated investment vehicle.

Skye Bioscience registers for the potential resale of up to 33.7 million shares of common stock by selling securityholders following a merger and several private placements.

Sow Good Inc. files an amendment to its Form S-1 registration statement, signaling its intent to proceed with a public offering and potential listing on the Nasdaq Capital Market.

CleanCore Solutions finalizes a $500,000 revolving credit agreement with Clayton Adams and adjusts its lease terms as it prepares for its initial public offering.

BestGofer Inc. is registering 2,080,000 common shares held by selling shareholders at a fixed price of $0.04 per share, with the intention of seeking quotation on the OTC Markets after the registration statement is effective.

BIOLASE, Inc. has filed a registration statement for the resale of up to 4,443,760 shares of its common stock, which are issuable upon the exercise of outstanding warrants held by a selling stockholder.

Fidelity is seeking SEC approval for its Fidelity Ethereum Fund, an exchange-traded product designed to track the performance of ether, the native token of the Ethereum blockchain.

Spyre Therapeutics is filing an amendment to its registration statement for the resale of up to 12 million shares of its common stock by selling stockholders.

FibroBiologics files an amendment to its S-1 registration statement to register the resale of approximately 1.5 million shares of common stock by GEM Global Yield LLC SCS and GEM Yield Bahamas Limited.

Actelis Networks has filed an amendment to its Form S-1 registration statement, covering the resale of up to 3,697,154 shares of common stock by selling stockholders.

Ensysce Biosciences is registering for the potential issuance and resale of up to 7,455,627 shares of common stock underlying warrants held by selling securityholders.

PACS Group, a leading post-acute healthcare company, has filed an amendment to its S-1 registration statement for an initial public offering of its common stock, with plans to list on the New York Stock Exchange under the symbol PACS.

Shorepower Technologies aims to register 25,817,272 shares of common stock for resale, including shares underlying warrants, to fund acquisitions and working capital.

Cyclacel Pharmaceuticals is launching a best efforts public offering of common stock, common stock warrants, and pre-funded warrants to raise capital for working capital and general corporate purposes.

Armlogi Holding Corp. files an amendment to its Form S-1 registration statement solely to include an updated consent from its independent auditor, ZH CPA, LLC.

Cortigent, a neurostimulation technology company, is seeking to raise approximately $15 million through an initial public offering to fund the development of its Orion visual prosthesis and stroke recovery system.

Churchill Capital Corp IX files for a $250 million IPO, offering units consisting of one Class A ordinary share and one-quarter of a warrant, aiming for a business combination.